Skip to main content
Livermore
Livermore
ZHEN

OrbiMed Advisors LLC

SEC CIK
0001055951
Latest filing
Aug 14, 2026

SVA holding history

Sinovac Biotech Ltd in every 13F filed by OrbiMed Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

SVA overviewAll 13F holders of SVAFull Q2 2026 holdings

Shares (Q2 2026)
2,718,735
Value
$184.5M
% of portfolio
3.5%
Quarters held
21
Since Q1 2021
Holdings of SVA by OrbiMed Advisors LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20262,718,735$184.5M3.5%00.0%UnchangedHolders
Q1 20262,718,735––00.0%UnchangedHolders
Q4 20252,718,735$184.5M3.8%00.0%UnchangedHolders
Q3 20252,718,735$184.5M4.4%00.0%UnchangedHolders
Q2 20252,718,735$334.0M8.4%00.0%UnchangedHolders
Q1 20252,718,735$334.0M8.0%00.0%UnchangedHolders
Q4 20242,718,735$334.0M6.9%00.0%UnchangedHolders
Q3 20242,718,735$340.0M6.2%00.0%UnchangedHolders
Q2 20242,718,735––00.0%UnchangedHolders
Q1 20242,718,735––00.0%UnchangedHolders
Q4 20232,718,735$340.0M6.8%00.0%UnchangedHolders
Q3 20232,718,735––00.0%UnchangedHolders
Q2 20232,718,735––00.0%UnchangedHolders
Q1 20232,718,735$340.0M6.7%00.0%UnchangedHolders
Q4 20222,718,735$340.0M6.5%00.0%UnchangedHolders
Q3 20222,718,735––00.0%UnchangedHolders
Q2 20222,718,735––+2,718,735NewHolders
Q1 20220$00.0%−2,839,500−100.0%Sold outHolders
Q4 20212,839,500––00.0%UnchangedHolders
Q3 20212,839,500––00.0%UnchangedHolders
Q2 20212,839,500––00.0%UnchangedHolders
Q1 20212,839,500––––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.